Elevated amyloidoses of human IAPP and amyloid beta by lipopolysaccharide and their mitigation by carbon quantum dotsElectronic supplementary information (ESI) available: XPS spectra with curve fitting (Fig. S1), TEM of IAPP and Aβ interacting with LPS (Fig. S2), ThT fluorescence of CQDs, LPS and ThT dye (Fig. S3), aggregation dynamics of IAPP and Aβ, in the presence and absence of LPS and a CQD, as revealed by DMD simulations (Fig. S4), secondary structures of IAPP and Aβ in the presence of LPS and CQDs, obtained by FTIR spectral deconvolution analyses and DMD simulations (Fig. S5 & S6), solved Aβ fibril structures (Fig. S7), hatching rates and ROS levels of zebrafish exposed to control treatments (Fig. S8), and band assignments in FTIR spectroscopy (Table S1). See DOI: 10.1039/d0nr02710c

Elevated amyloidoses of human IAPP and amyloid beta by lipopolysaccharide and their mitigation by carbon quantum dotsElectronic supplementary information (ESI) available: XPS spectra with curve fitting (Fig. S1), TEM of IAPP and Aβ interacting with LPS (Fig. S2), ThT fluorescence of CQDs, LPS and ThT dye (Fig. S3), aggregation dynamics of IAPP and Aβ, in the presence and absence of LPS and a CQD, as revealed by DMD simulations (Fig. S4), secondary structures of IAPP and Aβ in the presence of LPS and CQDs, obtained by FTIR spectral deconvolution analyses and DMD simulations (Fig. S5 & S6), solved Aβ fibril structures (Fig. S7), hatching rates and ROS levels of zebrafish exposed to control treatments (Fig. S8), and band assignments in FTIR spectroscopy (Table S1). See DOI: 10.1039/d0nr02710c